Hypoglycemia: While GLP-1 medications themselves rarely cause hypoglycemia (low blood sugar) when used as monotherapy, combining them with a mechanism of action that causes hypoglycemia such as insulin or sulfonylureas can increase the risk of hypoglycemia
If it has been more than five days, skip the missed dose and take the next dose on the regularly scheduled day
Fasting plasma glucose decreased by 4.7 mg/dL more in the semaglutide group than placebo, and HbA1c dropped by 0.24 percentage points more [4]
Include cardiology records documenting established CVD, current BMI, lifestyle modification history, and a Letter of Medical Necessity citing the SELECT trial results
The best strategy is to involve your prescriber, use basic monitoring where appropriate, and stop the supplement if unexpected problems begin
Its a question that some users of semaglutide and tirzepatide injections, sold as Wegovy and Zepbound for weight loss, have been asking as they report increased feelings of anxiety, depression and suicidal ideation prompting an evaluation from the US Food and Drug Administration this year
